NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Assembly Biosciences Inc (NASDAQ: ASMB)

 
ASMB Technical Analysis
5
As on 9th Jun 2023 ASMB STOCK Price closed @ 1.08 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.86 & Strong Sell for SHORT-TERM with Stoploss of 1.84 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ASMBSTOCK Price

Open 1.11 Change Price %
High 1.12 1 Day -0.04 -3.57
Low 1.05 1 Week 0.12 12.50
Close 1.08 1 Month 0.04 3.85
Volume 121355 1 Year -1.19 -52.42
52 Week High 2.45 | 52 Week Low 0.80
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
ASMB
Daily Charts
ASMB
Intraday Charts
Whats New @
Bazaartrend
ASMB
Free Analysis
 
ASMB Important Levels Intraday
RESISTANCE1.21
RESISTANCE1.17
RESISTANCE1.14
RESISTANCE1.12
SUPPORT1.04
SUPPORT1.02
SUPPORT0.99
SUPPORT0.95
 
ASMB Forecast May 2024
4th UP Forecast2.31
3rd UP Forecast1.92
2nd UP Forecast1.67
1st UP Forecast1.43
1st DOWN Forecast0.73
2nd DOWN Forecast0.49
3rd DOWN Forecast0.24
4th DOWN Forecast-0.15
 
ASMB Weekly Forecast
4th UP Forecast1.64
3rd UP Forecast1.46
2nd UP Forecast1.35
1st UP Forecast1.24
1st DOWN Forecast0.92
2nd DOWN Forecast0.81
3rd DOWN Forecast0.70
4th DOWN Forecast0.52
 
ASMB Forecast2024
4th UP Forecast4.32
3rd UP Forecast3.28
2nd UP Forecast2.64
1st UP Forecast2
1st DOWN Forecast0.16
2nd DOWN Forecast-0.48
3rd DOWN Forecast-1.12
4th DOWN Forecast-2.16
 
 
ASMB Other Details
Segment EQ
Market Capital 143009696.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ASMB Address
ASMB
 
ASMB Latest News
 
Your Comments and Response on Assembly Biosciences Inc
 
ASMB Business Profile
Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. It also has a clinical collaboration agreement with Antios Therapeutics, Inc. to evaluate a triple combination treatment in patients with chronic hepatitis B virus infection. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California. Address: 331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service